Drug-induced Cardiac Mitochondrial Toxicity and Protection: From Doxorubicin to Carvedilol

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|20|2113-2129

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.20, 2011-07, pp. : 2113-2129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug-induced mitochondrial toxicity

By Chan Katie   Truong Don   Shangari Nandita   O’Brien Peter J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 4, 2005-12 ,pp. : 655-669

Informa Healthcare

Access to resources Recommend Favorite

New Insights in Drug-Induced Mitochondrial Toxicity

By  

Current Pharmaceutical Design, Vol. 17, Iss. 20, 2011-07 ,pp. : 2100-2112

Bentham Science Publishers

Access to resources Recommend Favorite

Multiple Targets for Drug-Induced Mitochondrial Toxicity

By  

Current Medicinal Chemistry, Vol. 22, Iss. 20, 2015-01 ,pp. : 2488-2492

Bentham Science Publishers

Access to resources Recommend Favorite

Drug-induced mitochondrial dysfunction in cardiac and skeletal muscle injury

By Sardo Vilma A   Pereira Sandro L   Oliveira Paulo J  

Expert Opinion on Drug Safety, Vol. 7, Iss. 2, 2008-03 ,pp. : 129-146

Informa Healthcare

Access to resources Recommend Favorite

Cardiac troponins as biomarkers of drug- and toxin-induced cardiac toxicity and cardioprotection

By Gaze David C   Collinson Paul O  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 4, 2005-12 ,pp. : 715-725

Informa Healthcare

Access to resources Recommend Favorite